Bridging the gap between high-throughput genetic and transcriptional data reveals cellular pathways responding to alpha-synuclein toxicity

Cells respond to stimuli by changes in various processes, including signaling pathways and gene expression. Efforts to identify components of these responses increasingly depend on mRNA profiling and genetic library screens, yet the functional roles of the genes identified by these assays often remain enigmatic. By comparing the results of these two assays across various cellular responses, we found that they are consistently distinct. Moreover, genetic screens tend to identify response regulators, while mRNA profiling frequently detects metabolic responses. We developed an integrative approach that bridges the gap between these data using known molecular interactions, thus highlighting major response pathways. We harnessed this approach to reveal cellular pathways related to alpha-synuclein, a small lipid-binding protein implicated in several neurodegenerative disorders including Parkinson disease. For this we screened an established yeast model for alphasynuclein toxicity to identify genes that when overexpressed alter cellular survival. Application of our algorithm to these data and data from mRNA profiling provided functional explanations for many of these genes and revealed novel relations between alpha-synuclein toxicity and basic cellular pathways. Cells live in a dynamic environment in which they confront various perturbations such as sudden environmental changes, toxins, and mutations. The response to such perturbations is #To whom correspondence should be addressed. E-mail: lindquist_admin@wi.mit.edu (S. L.); fraenkel-admin@mit.edu (E.F.). 7Present Address: Department of Cell and Developmental Biology, The University of Pennsylvania, Philadelphia, PA, USA 8Present Address: Medical College of Georgia, Augusta, GA, USA 9Present Address: Boston Biomedical Research Institute, Watertown, MA, USA. *These authors contributed equally to this work +These authors contributed equally to this work Summary: A novel approach that integrates genetic hits, differentially expressed genes and known molecular interactions reveals a dramatically enhanced view of cellular responses and was used to create the first cellular map of alpha-synuclein toxicity. NIH Public Access Author Manuscript Nat Genet. Author manuscript; available in PMC 2009 September 1. Published in final edited form as: Nat Genet. 2009 March ; 41(3): 316–323. doi:10.1038/ng.337. N IH PA Athor M anscript N IH PA Athor M anscript N IH PA Athor M anscript typically complex and comprises signaling and metabolic changes, as well as changes in gene expression. Revealing the cellular mechanisms responding to a specific perturbation may unravel its nature, thus illuminating disease mechanisms1 or a drug’s mode of action2 ,3, and identify points of intervention with potential therapeutic value4. High-throughput experimental techniques including mRNA profiling and genetic screening are commonly used for revealing components of these response pathways because they provide a genomeand proteome-wide view of molecular changes. mRNA profiling experiments rapidly identify genes that are differentially expressed following stimuli. Genetic screening, including deletion, overexpression and RNAi library screens, identify genetic “hits”, genes whose individual manipulation alters the phenotype of stimulated cells. However, each technique has obvious limitations for revealing the full nature of cellular responses. mRNA profiling experiments do not target the series of events that led to the differential expression. Genetic screens provide strong evidence that a gene is functionally related to the response process. Yet, this relationship is often indirect and hard to decipher, especially in highthroughput experiments that typically result in scores of relevant genes with various functions. It has been noted previously in a few specific instances 2,5–9 that genetic screens do not identify the same genes as mRNA assays conducted in the same conditions. By analyzing the relationship between genetic hits and differentially expressed genes across 179 diverse conditions, we found that this discrepancy is, in fact, a general rule. Furthermore, we found a striking bias in each technique that led us to a new, more coherent view of cellular responses. To bridge the gap between the two forms of high throughput analysis we developed an algorithm that exploits these experimental biases and that takes advantage of molecular interactions data. This approach simultaneously reveals (i) the functional context of genetic hits, and (ii) additional proteins that participate in the response yet were not detected by either the genetic or the mRNA profiling assays themselves. Having validated our approach in a wide array of perturbations, we applied it to unravel cellular responses to increased expression of alpha-synuclein. Alpha-synuclein is a small human protein implicated in Parkinson disease whose native function and role in the etiology of the disease remain unclear 10. We screened an established yeast model for alpha-synuclein toxicity 11,12 using an additional set of 3,500 overexpression yeast strains, exposing the multifaceted toxicity of alpha-synuclein. Application of our approach to the high-throughput genetic and transcriptional data of the yeast model illuminated response pathways whose manipulation altered cellular survival, and provided the first cellular map of the proteins and genes responding to alpha-synuclein expression. The relationship between genetic hits and differentially expressed genes In order to derive a comprehensive view of the relationship between genetic hits and differentially expressed genes identified in a particular condition, we analyzed published mRNA profiles and genetic hits for 179 distinct perturbations in yeast (Methods). These data included responses to a wide array of chemical and genetic insults affecting a multitude of cellular processes. For 30 of these perturbations complete genetic screens were reported, typically identifying >100 genetic hits; only partial genetic data are available for the remaining perturbations. The number of genetic hits, differentially expressed genes and genes common to both for each perturbation are given in Table 1 and Supplementary Table 1. Intriguingly, in almost all cases the overlap was astonishingly small and statistically insignificant (p>0.05, Methods). One possible explanation for the poor overlap between genetic hits and differentially expressed genes is that each assay may be biased toward distinct aspects of cellular responses. Analysis Yeger-Lotem et al. Page 2 Nat Genet. Author manuscript; available in PMC 2009 September 1. N IH PA Athor M anscript N IH PA Athor M anscript N IH PA Athor M anscript of Gene Ontology (GO) enrichment confirmed this hypothesis (Methods). The combined hits from all 179 genetic screens were highly enriched for the annotations biological regulation (23.3%, p<10−82), transcription (14%, p<10−44) and signal transduction (6.3%, p<10−30). In contrast, the regulated genes from all perturbations were enriched mostly for various metabolic processes (e.g., organic acid metabolic process 7.1%, p<10−18) and oxidoreductase activities 7.2%, p< 10−34). To ensure these patterns of enrichment do not stem from a handful of data sources but reflect a general tendency, we also analyzed the 30 perturbations for which complete data were available. We found the same enrichment trends, regardless of whether these perturbations were analyzed individually (Supplementary Table 2) or whether all 30 datasets were combined (Supplementary Table 3). Complete enrichment analyses appear in Supplementary Text. Thus, we find that genetic assays tend to probe the regulation of cellular responses, while mRNA profiling assays tend to probe the metabolic aspects of cellular responses. The striking differences in annotations between genetic hits and differentially expressed genes imply that each gene set alone often provides a limited and biased view of cellular responses. In fact, this hypothesis was often borne out in cases where the pathways are well-studied by other, more classical methods of genetic and molecular biological research. In the yeast DNA damage response pathway, for example, a genetic screen 4 detected proteins that sense DNA damage (Mec3, Ddc1, Rad17 and Rad24), while mRNA profiling detected repair enzymes such as Rnr4 13. Yet core components of this pathway that had been uncovered by other intense investigations over many years, such as the signal transducers Mec1 and Rad53 and the transcription factor Rfx1, remained undetected by either high-throughput assay. If we are to fully reap the benefits of applying high-throughput methods to new problems and under-explored biological processes, it is essential that we find new routes to connect these data and obtain a true picture of the regulation of cellular responses. Here we provide a novel framework that bridges the gap between genetic and transcriptional data. Based on known pathways such as the response to DNA damage discussed above, we expect that some of the genetic hits, which are enriched for response regulators, will be connected via regulatory pathways to the differentially regulated genes, which are the output of such pathways. Discovering these pathways may uncover additional components of the cellular response to perturbation that are missing from the experimental data (Figure 1). ResponseNet algorithm for identification of response networks The ResponseNet algorithm identifies molecular interaction paths connecting genetic hits and differentially expressed genes that may include hidden components of the cellular response (Figure 1). The yeast Saccharomyces cerevisiae provides a powerful model system for such analysis due to the extensive molecular interactions data now available (Methods and Supplementary Table 4). Taking advantage of these resources we assembled an integrated network model of the yeast interactome that contains protein-prot

[1]  R. Shamir,et al.  From E-MAPs to module maps: dissecting quantitative genetic interactions using physical interactions , 2008, Molecular systems biology.

[2]  R. Krüger,et al.  Review: Familial Parkinson's disease – genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease , 2008, Neuropathology and applied neurobiology.

[3]  Susana R. Neves,et al.  Design Logic of a Cannabinoid Receptor Signaling Network That Triggers Neurite Outgrowth , 2008, Science.

[4]  Xuemei Huang,et al.  Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu‐Asia Aging Study , 2008, Movement disorders : official journal of the Movement Disorder Society.

[5]  Yonina C. Eldar,et al.  eQED: an efficient method for interpreting eQTL associations using protein networks , 2008, Molecular systems biology.

[6]  R. Sharan,et al.  A systems-level approach to mapping the telomere length maintenance gene circuitry , 2008, Molecular systems biology.

[7]  Stephen J. Elledge,et al.  Profiling Essential Genes in Human Mammary Cells by Multiplex RNAi Screening , 2008, Science.

[8]  A. Schapira Mitochondria in the aetiology and pathogenesis of Parkinson's disease , 2008, The Lancet Neurology.

[9]  S. Lindquist,et al.  The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis , 2008, Proceedings of the National Academy of Sciences.

[10]  S. Lindquist,et al.  The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. , 2008, Proceedings of the National Academy of Sciences of the United States of America.

[11]  K. Gunsalus,et al.  Network modeling links breast cancer susceptibility and centrosome dysfunction. , 2007, Nature genetics.

[12]  S. Ohlmeier,et al.  NO-mediated apoptosis in yeast , 2007, Journal of Cell Science.

[13]  Fred Winston,et al.  Heme Levels Switch the Function of Hap1 of Saccharomyces cerevisiae between Transcriptional Activator and Transcriptional Repressor , 2007, Molecular and Cellular Biology.

[14]  Trey Ideker,et al.  Integrating physical and genetic maps: from genomes to interaction networks , 2007, Nature Reviews Genetics.

[15]  Roded Sharan,et al.  SPINE: a framework for signaling-regulatory pathway inference from cause-effect experiments , 2007, ISMB/ECCB.

[16]  W. Mandemakers,et al.  A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases , 2007, Journal of Cell Science.

[17]  Pasko Rakic,et al.  The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease , 2007, Proceedings of the National Academy of Sciences.

[18]  D. Rubinsztein,et al.  Trehalose, a Novel mTOR-independent Autophagy Enhancer, Accelerates the Clearance of Mutant Huntingtin and α-Synuclein* , 2007, Journal of Biological Chemistry.

[19]  P. Bastiaens,et al.  Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate , 2007, Nature Cell Biology.

[20]  Richard W. Murrow,et al.  Lower low‐density lipoprotein cholesterol levels are associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[21]  M. Spillantini,et al.  Physiological and pathological properties of alpha-synuclein. , 2007, Cellular and molecular life sciences : CMLS.

[22]  J. Trojanowski,et al.  Mechanisms of Parkinson's Disease Linked to Pathological α-Synuclein: New Targets for Drug Discovery , 2006, Neuron.

[23]  E. Ruppin,et al.  Multiple knockout analysis of genetic robustness in the yeast metabolic network , 2006, Nature Genetics.

[24]  S. Lindquist,et al.  α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.

[25]  Susan Lindquist,et al.  Flanking sequences profoundly alter polyglutamine toxicity in yeast. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Li Wang,et al.  An integrative approach for causal gene identification and gene regulatory pathway inference , 2006, ISMB.

[27]  Madhukar S. Dasika,et al.  A computational framework for the topological analysis and targeted disruption of signal transduction networks. , 2006, Biophysical journal.

[28]  T. Ideker,et al.  Comprehensive curation and analysis of global interaction networks in Saccharomyces cerevisiae , 2006, Journal of biology.

[29]  Takashi Uehara,et al.  S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration , 2006, Nature.

[30]  A. Barabasi,et al.  A Protein–Protein Interaction Network for Human Inherited Ataxias and Disorders of Purkinje Cell Degeneration , 2006, Cell.

[31]  Hamid Bolouri,et al.  Expression and functional profiling reveal distinct gene classes involved in fatty acid metabolism , 2006, Molecular systems biology.

[32]  J. Shulman,et al.  TOR-Mediated Cell-Cycle Activation Causes Neurodegeneration in a Drosophila Tauopathy Model , 2006, Current Biology.

[33]  D. Price,et al.  Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death , 2006, The Journal of Neuroscience.

[34]  R. Schneggenburger,et al.  A Systems Approach to Mapping DNA Damage Response Pathways , 2006 .

[35]  D. Price,et al.  Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  T. Dawson Parkin and defective ubiquitination in Parkinson's disease. , 2006, Journal of neural transmission. Supplementum.

[37]  Ting Wang,et al.  An improved map of conserved regulatory sites for Saccharomyces cerevisiae , 2006, BMC Bioinformatics.

[38]  Matthew A. Hibbs,et al.  Discovery of biological networks from diverse functional genomic data , 2005, Genome Biology.

[39]  Sean R. Collins,et al.  Exploration of the Function and Organization of the Yeast Early Secretory Pathway through an Epistatic Miniarray Profile , 2005, Cell.

[40]  John D. Storey,et al.  A network-based analysis of systemic inflammation in humans , 2005, Nature.

[41]  J. Thornton,et al.  A novel degron-mediated degradation of the RTG pathway regulator, Mks1p, by SCFGrr1. , 2005, Molecular biology of the cell.

[42]  J. Derisi,et al.  Fzf1p regulates an inducible response to nitrosative stress in Saccharomyces cerevisiae. , 2005, Molecular biology of the cell.

[43]  Thomas J. Begley,et al.  Genome-wide responses to DNA-damaging agents. , 2005, Annual review of microbiology.

[44]  C. A. Froelich,et al.  Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease. , 2005, Journal of molecular biology.

[45]  T. Dawson,et al.  To die or grow: Parkinson's disease and cancer , 2005, Trends in Neurosciences.

[46]  T. Ideker,et al.  Systematic interpretation of genetic interactions using protein networks , 2005, Nature Biotechnology.

[47]  G. Church,et al.  A global view of pleiotropy and phenotypically derived gene function in yeast , 2005, Molecular systems biology.

[48]  Andrew Emili,et al.  Navigating the Chaperone Network: An Integrative Map of Physical and Genetic Interactions Mediated by the Hsp90 Chaperone , 2005, Cell.

[49]  P. Auluck,et al.  Mechanisms of Suppression of {alpha}-Synuclein Neurotoxicity by Geldanamycin in Drosophila. , 2005, The Journal of biological chemistry.

[50]  Thomas J. Begley,et al.  Global network analysis of phenotypic effects: Protein networks and toxicity modulation in Saccharomyces cerevisiae , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[51]  T. Ideker,et al.  Integrating phenotypic and expression profiles to map arsenic-response networks , 2004, Genome Biology.

[52]  Trey Ideker,et al.  Hot spots for modulating toxicity identified by genomic phenotyping and localization mapping. , 2004, Molecular cell.

[53]  H. Lehrach,et al.  A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. , 2004, Molecular cell.

[54]  Nicola J. Rinaldi,et al.  Transcriptional regulatory code of a eukaryotic genome , 2004, Nature.

[55]  Tommi S. Jaakkola,et al.  Physical Network Models , 2004, J. Comput. Biol..

[56]  Francesco Scaravilli,et al.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease , 2004, Nature Genetics.

[57]  R. Milo,et al.  Network motifs in integrated cellular networks of transcription-regulation and protein-protein interaction. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[58]  C. Olanow,et al.  Manganese‐Induced Parkinsonism and Parkinson's Disease , 2004, Annals of the New York Academy of Sciences.

[59]  Gary D Bader,et al.  Global Mapping of the Yeast Genetic Interaction Network , 2004, Science.

[60]  Grant W. Brown,et al.  Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways , 2004, Nature Biotechnology.

[61]  S. Lindquist,et al.  Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology , 2003, Science.

[62]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[63]  A. Abeliovich,et al.  Parkin Is a Component of an SCF-like Ubiquitin Ligase Complex and Protects Postmitotic Neurons from Kainate Excitotoxicity , 2003, Neuron.

[64]  Alfonso Valencia,et al.  Life cycles of successful genes. , 2003, Trends in genetics : TIG.

[65]  A. Singleton,et al.  alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.

[66]  Charles Boone,et al.  A genome-wide screen for methyl methanesulfonate-sensitive mutants reveals genes required for S phase progression in the presence of DNA damage , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Ronald W Davis,et al.  Parallel phenotypic analysis of sporulation and postgermination growth in Saccharomyces cerevisiae , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[68]  S. Shen-Orr,et al.  Network motifs: simple building blocks of complex networks. , 2002, Science.

[69]  M. G. Koerkamp,et al.  Dissection of transient oxidative stress response in Saccharomyces cerevisiae by using DNA microarrays. , 2002, Molecular biology of the cell.

[70]  Ronald W. Davis,et al.  Transcriptional response of Saccharomyces cerevisiae to DNA-damaging agents does not identify the genes that protect against these agents , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[71]  S. Lindquist,et al.  Defining a pathway of communication from the C-terminal peptide binding domain to the N-terminal ATPase domain in a AAA protein. , 2002, Molecular cell.

[72]  C. Ball,et al.  Saccharomyces Genome Database. , 2002, Methods in enzymology.

[73]  Gary D Bader,et al.  Systematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants , 2001, Science.

[74]  D. Botstein,et al.  Genomic expression responses to DNA-damaging agents and the regulatory role of the yeast ATR homolog Mec1p. , 2001, Molecular biology of the cell.

[75]  D. Botstein,et al.  Genomic expression programs in the response of yeast cells to environmental changes. , 2000, Molecular biology of the cell.

[76]  Yudong D. He,et al.  Functional Discovery via a Compendium of Expression Profiles , 2000, Cell.

[77]  Ronald W. Davis,et al.  Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. , 1999, Science.

[78]  J. Lis,et al.  Glycogen Synthase Phosphatase Interacts with Heat Shock Factor To Activate CUP1 Gene Transcription inSaccharomyces cerevisiae , 1999, Molecular and Cellular Biology.

[79]  Dmitrij Frishman,et al.  MIPS: a database for genomes and protein sequences , 1999, Nucleic Acids Res..

[80]  R. Vanderbei LOQO user's manual — version 3.10 , 1999 .

[81]  Michael R. Green,et al.  Dissecting the Regulatory Circuitry of a Eukaryotic Genome , 1998, Cell.

[82]  R. Voellmy,et al.  Repression of Heat Shock Transcription Factor HSF1 Activation by HSP90 (HSP90 Complex) that Forms a Stress-Sensitive Complex with HSF1 , 1998, Cell.

[83]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[84]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.

[85]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.

[86]  Ronald L. Rivest,et al.  Introduction to Algorithms , 1990 .